SpineGuard Validates Results of New Ultrasonic Technology
French company SpineGuard announces the successful defense of a doctoral thesis presenting the results obtained with a robot-assisted ultrasonic technology intended for spinal surgery. This innovation complements the group's existing DSG technology.
Jorge Andrés Pérez Velásquez, a doctoral engineering student at SpineGuard, successfully defended his thesis on December 11 in Paris, the company reports. The presented work focuses on a robotically assisted ultrasonic technology that determines the entry point and pedicular trajectory from the bone surface of the spine. According to the group, this defense marks the second validation by the scientific community of the feasibility of this innovation, following a presentation at the CFA congress last April.
Enhancement of Existing Technology
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The new ultrasonic technology, patented by SpineGuard, complements the company's existing DSG technology, the statement specifies. It enables the determination of the entry point and drilling direction from the posterior surface of the bone without the use of X-rays, before the DSG-equipped drill penetrates the bone. According to Stéphane Bette, deputy CEO and co-founder of SpineGuard, secure drilling with automatic breach detection has already been validated by previously published works.
Collaboration and Future Steps
These results stem from the collaboration between SpineGuard and Sorbonne University, the group emphasizes. The company indicates that the next step involves seeking an industrial partner to exploit this technology. SpineGuard notes that more than 110,000 surgeries have been secured to date using its DSG technology, whose reliability and precision have been established by 39 studies published in leading medical journals.
La transformation progressive du modèle commercial et l'amélioration des marges en 2025 illustrent la dynamique du groupe.
Résultats annuels 2025: chiffre d'affaires de 3 757 K€, marge brute de 78,9%, EBIT courant de -1 660 K€, résultat net de -2 068 K€. La marge brute s'établit à 78,9% et la direction souligne une amélioration opérationnelle grâce à la transformation du modèle commercial et à la réduction des coûts, tout en rappelant le financement obligataire et l'objectif d'équilibre opérationnel pour fin 2026.
Outlook / guidance
Management commentary: L'entreprise vise l'équilibre opérationnel d'ici la fin de l'année 2026 et prévoit de couvrir ses besoins de financement jusqu'au 2e trimestre 2027, sous réserve des conditions du marché et de la poursuite des partenariats stratégiques.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.